Clinical Trials Directory

Trials / Completed

CompletedNCT06974045

Impact of COVID-19 Pandemic on Single-stage Laparoscopic Cholecystectomy and Laparoscopic Common Bile Duct Exploration Service

Evaluation of a Single-stage Laparoscopic Cholecystectomy and Laparoscopic Common Bile Duct Exploration Service Pre-, Intra- and Post-COVID-19 Pandemic: a Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
237 (actual)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

Choledocholithiasis is reported to be present in 15-20% of patients with symptomatic gallstones. The single-stage management consists of performing either laparoscopic common bile duct exploration (LCBDE) or intraoperative endoscopic retrograde cholangiopancreatography (ERCP) at the same time as laparoscopic cholecystectomy (LC). Since the Coronavirus (COVID-19) pandemic, surgical practice has significantly been impacted. The pandemic has had ramifications on patient and staff safety, surgical techniques, minimally invasive procedures, theatre workflow, education and training. The investigators analysed a series of LCBDE procedures in our institution pre-, intra- and post-COVID-19 pandemic to assess the feasibility, efficacy and safety of this single-stage treatment approach following the pandemic.

Conditions

Interventions

TypeNameDescription
OTHERSingle-stage LC + LCBDECholedochotomy and transductal common bile duct exploration or transcystic choledochoscopy and common bile duct exploration

Timeline

Start date
2016-04-01
Primary completion
2024-02-01
Completion
2025-05-01
First posted
2025-05-15
Last updated
2026-03-27

Source: ClinicalTrials.gov record NCT06974045. Inclusion in this directory is not an endorsement.